Radical radiotherapy of localised prostate cancer: The relationship between radiation dose and survival

Cancer/Radiotherapie

Volumn 2, Issue 4, 1998, Pages 351-358

  Magrini, S M ^a   Cellai, E ^a   Pertici, M ^a   Rossi, F ^a   Ponticelli, P ^b   Odantini, R ^b   Cappellini, M ^a   Biti, G P ^a  

^a University Hospital   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

Author keywords

Dose; Prostate cancer; Radiotherapy

Indexed keywords

ANTIANDROGEN; GONADORELIN AGONIST; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY;

EID: 0032124061     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(98)80346-6     Document Type: Article

References (17)

1. 1 Aristizabal SA, Steinbroun D, Heusinkveld RS. External beam radiotherapy in cancer of the prostate. The University of Arizona experience. Radiother Oncol 1984 ; 1 : 309-15
2. 2 Bagshaw MA, Cox RS, Ray GR. Status of radiation treatment of prostate cancer at Stanford University. NCI Monogr 1988 ; 7 : 47-60
3. e congrès de l'American Society for Therapeutic Radiology and Oncology (ASTRO), Los Angeles, 27-31 octobre 1996. Cancer/Radiother 1997 ; 1 : 88-93
4. 4 Del Regato JA, Trailins AH, Pittman DD. Twenty years follow up of patients with inoperable cancer of the prostate (Stage C) treated by radiotherapy: report of a national cooperative study. Int J Radiation Oncology Biol Phys 1993 ; 26 : 197-201
5. 5 Epstein B, Peter R, Martin E, Hunt M, Hanks GE. Low complications rate with conformal radiotherapy for cancer of the prostate. (Abstract) Radiother Oncol 1992 ; 24 Suppl : S100
6. 6 Hanks GE, Leibel S, Krall JM, Kramer S. Dose-response observations for local control of adenocarcinoma of the prostate. Int J Radiation Oncology Biol Phys 1985 ; 11 : 153-7
7. 7 Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiation Oncology Biol Phys 1988 ; 15 : 1299-305
8. 8 Hanks GE, Krall JM, Hanlon AL, Asbell SO, Pilepich MV, Owen JB. Patterns of care and RTOG studies in prostate cancer: long term survival, hazard rate observations, and possibilities of cure. Int J Radiation Oncology Biol Phys 1993 ; 28 : 39-45
9. 9 Hanks GE, Lee WR, Hanlon AL, Hunt M, Kaplan E, Epstein BE et al. Conformal technique dose escalation for prostate cancer; biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen > = 10 ng/mL. Int J Radiation Oncology Biol Phys 1996 ; 35 : 861-8
10. 10 Jewett HJ. The present status of radical prostatectomy for Stages A and B prostatic cancer. Urol Clin North Am 1975 ; 2 : 105
11. 11 Ljung G, Haggman M, Hansson H, Holmberg L, Nilsson S. Adverse effect after radical external beam radiotherapy of localized prostatic adenocarcinoma using two-dimensional dose-planning and a limited field technique. Acta Oncol 1996 ; 4 : 445-50
12. 12 Neglia WJ, Hussey DH, Johnson DE. Megavoltage radiation therapy for carcinoma of the prostate. Int J Radiation Oncology Biol Phys 1977 ; 2 : 873-82
13. 13 Perez CA, Garcia D, Simpson JR, Zivnuska F, Lockett MA. Factors influencing outcome of definitive radiotherapy for localized carcinoma of the prostate. Radiother Oncol 1989 ; 16 : 1-21
14. 14 Sandler HM, Perez-Tamayo C, Ten Haken RK, Lichter AS. Dose escalation for Stage C (T3) prostate cancer: minimal rectal toxicity observed using conformal therapy. Radiother Oncol 1992 ; 23 : 53-4
15. 15 Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Phil D, Urie MM et al. Advanced prostate cancer: The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiation Oncology Biol Phys 1995 ; 32 : 3-12
16. 16 Zagars GK, Pollack A, Von Eschenbach AC. Prostate cancer and radiation therapy - The message conveyed by serum prostate-specific antigen. Int J Radiation Oncology Biol Phys 1995 ; 33 : 23-35
17. 17 Zagars GK, Johnson DE, von Eschenbach AC, Hussey DH. Adjuvant estrogen following radiation therapy for stage C adenocarcinoma of the prostate: long term results of a prospective randomized study. Int J Radiation Oncology Biol Phys 1988 ; 14 : 1085-91